Adenoviral 15-lipoxygenase-1 gene transfer inhibits hypoxia -induced proliferation of retinal microvascular endothelial cells in vitro

被引:7
作者
Yan, Ying [1 ,2 ]
He, Tao [1 ]
Shen, Ying [1 ]
Chen, Xiao [2 ]
Diao, Bo [2 ]
Li, Zhi [3 ]
Liu, Qing [2 ]
Xing, Yi-Qiao [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Ophthalmol, Wuhan 430060, Hubei Province, Peoples R China
[2] Guangzhou Mil Command Chinese PLA, Wuhan Gen Hosp, Dept Ophthalmol, Wuhan 430070, Hubei Province, Peoples R China
[3] Xiangyang Ctr Hosp, Dept Ophthalmol, Xiangyang 441021, Hubei Province, Peoples R China
基金
中国国家自然科学基金;
关键词
15-Lipoxygenase-1; hypoxia; retinal microvascular endothelial cells; retinal neovascularization; GROWTH-FACTOR; LIPOXYGENASE-ISOFORMS; DIABETIC-RETINOPATHY; EXPRESSION; NEOVASCULARIZATION; BEVACIZUMAB; ATHEROSCLEROSIS; ANGIOGENESIS; RANIBIZUMAB; EPITHELIUM;
D O I
10.3980/j.issn.2222-3959.2012.05.04
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
AIM: To investigate whether 15-Lipoxygenase-1 (15-LOX-1) plays an important role in the regulation of angiogenesis, inhibiting hypoxia-induced proliferation of retinal microvascular endothelial cells (RMVECs) and the underlying mechanism. METHODS: Primary RMVECs were isolated from the retinas of C57/BL63 mice and identified by an evaluation for FITC-marked CD31. The hypoxia models were established with the Bio-bag and evaluated with a blood-gas analyzer. Experiments were performed using RMVECs treated with and without transfer. Ad-15-LOX-1 or Ad-vector both under hypoxia and normoxia condition at 12, 24, 48, 72 hours. The efficacy of the gene transfer was assessed by immunofluorescence staining. Cells proliferation was evaluated by the CCK-8 method. RNA and protein expressions of 15-LOX-1, VEGF-A, VEGFR-2, eNOs and PPAR-r were analyzed by real-time reverse transcription polymerase chain reaction (RT-PCR) and Western blot. RESULTS: Routine evaluation for FITC-marked CD31 showed that cells were pure. The results of blood-gas analysis showed that when the cultures were exposed to hypoxia for more than 2 hours, the Po2 was 4.5 to 5.4 Kpa. We verified RMVECs could be infected with Ad-LS-LOX-for Ad-vectorvia Fluorescence microscopy. CCK-8 analysis revealed that the proliferative capacities of RMVECs in hypoxic group were significantly higher at each time point than they were in normoxic group (P <0.05). In a hypoxic condition, the proliferative capacities of RMVECs in 15-LOX-1 group were significantly inhibited (P<0.05). Real-time RT-PCR analysis revealed that the expressions of VEGF-A, VEGF-R2 and eNOs mRNA increased in hypoxia group compared with normoxia group (P<0.01). However, the expressions of 15-LOX-1, PPAR-r mRNA decreased in hypoxia group compared with normoxia group (P<0.01). It also showed that in a hypoxic condition, the expressions of VEGF-A, VEGF-R2 and eNOs mRNA decreased significantly in 15-LOX-1 group compared with hypoxia group (P<0.01). However, 15-LOX-1 and PPAR-r mRNA increased significantly in 15-LOX-1 group compared with hypoxia group (P<0.01). There was no significant difference of the mRNA expressions between vector group and hypoxia group (P>0.05). Western blot analysis revealed that the expressions of relative proteins were also ranked in that order. CONCLUSION: Our results suggested that 15-LOX-1 and PPAR-r might act as a negative regulator of retinal angiogenesis. And the effect of 15-LOX-1 overexpression is an anti-angiogenic factor in hypoxia-induced retinal neovascularization (RNV). Overexpression 15-LOX-1 on RMVECs of hypoxia-induced RNV blocked signaling cascades by inhibiting hypoxia-induced increases in VEGF family. PPAR-r effect on VEGFR(2) could be an additional mechanism whereby 15-LOX-1 inhibited the hypoxia-induced RNV.
引用
收藏
页码:562 / 569
页数:8
相关论文
共 33 条
  • [1] SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS
    AIELLO, LP
    PIERCE, EA
    FOLEY, ED
    TAKAGI, H
    CHEN, H
    RIDDLE, L
    FERRARA, N
    KING, GL
    SMITH, LEH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) : 10457 - 10461
  • [2] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [3] Combination therapy for the treatment of ocular neovascularization
    Bradley J.
    Ju M.
    Robinson G.S.
    [J]. Angiogenesis, 2007, 10 (2) : 141 - 148
  • [4] Discovery of a second 15S-lipoxygenase in humans
    Brash, AR
    Boeglin, WE
    Chang, MS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) : 6148 - 6152
  • [5] Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate
    Brash, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) : 23679 - 23682
  • [6] 15-Lipoxygenase - A Janus enzyme?
    Chanez, P
    Bonnans, C
    Chavis, C
    Vachier, I
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 27 (06) : 655 - 658
  • [7] Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice
    Cyrus, T
    Witztum, JL
    Rader, DJ
    Tangirala, R
    Fazio, S
    Linton, MF
    Funk, CD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) : 1597 - 1604
  • [8] What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?
    Fuerstenberger, G.
    Krieg, P.
    Mueller-Decker, K.
    Habenicht, A. J. R.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (10) : 2247 - 2254
  • [9] The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice
    Funk, CD
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1304 (01): : 65 - 84
  • [10] Retinal angiogenesis in development and disease
    Gariano, RF
    Gardner, TW
    [J]. NATURE, 2005, 438 (7070) : 960 - 966